当前位置： 主页 > News

News

Hoyotek and Wantai Biopharm Announce Strategic Partnership in Neurological Diagn

Hoyotek and Wantai Biopharm Announce Strategic Partnership in Neurological Diagn

June23,2025–HoyotekBiomedicalCo.,Ltd.andWantaiBioPharmCo.,Ltd.announcedastrategiccollaborationtoco-developprecisiondiagnosticsolutionsforneurodegenerativedisorders.ThepartnershipwillintegrateHoyotek&...

Hoyotek AD Rapid Test Kit Receives MOH Certification in Malaysia

Hoyotek AD Rapid Test Kit Receives MOH Certification in Malaysia

Hoyotek'sAmyloidBeta(1-42)/PhosphorylatedTau181RapidTestKit(FluorescenceImmunochromatographicAssay)hassuccessfullyobtainedtheregistrationcertificatefromtheMalaysianMinistryofHealth(MOH).Thismarksa...

Donation 200,000 RMB Alzheimer's Disease test reagents in Nov 2023

Donation 200,000 RMB Alzheimer's Disease test reagents in Nov 2023

Donation 200,000 RMB Alzheimer's Disease test reagents in Nov 2023

Hoyotek Shines at the 2023 Vietnam International Medical Exhibition

Hoyotek Shines at the 2023 Vietnam International Medical Exhibition

Hoyotek participated in the PHARMEDI VIETNAM exhibition.

We have once again been honored with 51 EU CE certificates, 30 NMPA certificates

We have once again been honored with 51 EU CE certificates, 30 NMPA certificates

Test procedure-Corona Virus (COVID-19) Antigen Rapid Test (Colloidal Gold)

Test procedure-Corona Virus (COVID-19) Antigen Rapid Test (Colloidal Gold)

Our company COVID-19 Product obtained CE certification.

Our company COVID-19 Product obtained CE certification.

OurcompanyCOVID-19ProductobtainedCEcertification.Category：CompanyNewsPublishedDate：2020-12-15OnDecember8,2020, HoyotekBiomedicalCo.,Ltd.CoronaVirusDisease2019(COVID-19)ProductCoronaVirus(COVID-1...

Our company joined the Biomanufacturing Industry (Talent) A

Our company joined the Biomanufacturing Industry (Talent) A

News